Antibacterial potential of nanobioceramics used as drug carriers
Handbook of Bioceramics and Biocomposites, Page: 1333-1373
2016
- 8Citations
- 18Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Infectious diseases continue to be one of the major challenges faced by the medical community despite many advancements in the field of health care and research. Alarmingly infections, which were the leading cause of death worldwide a hundred years ago, have made a dramatic resurgence. This comeback is mainly attributed to the resistance shown by the bacteria to major antimicrobial drugs that are currently used. Attempts have been made to overcome this crisis by discovering newer antibiotics and developing efficient modes of drug delivery. In this regard, the role of nanotechnology in infection control has evinced tremendous interest especially with the development of nanocarriers for antibiotics delivery and antibacterial nanoparticles. Bioceramics, a class of inorganic biomaterials, are widely used as bone substitutes for bone reconstruction. Using bioceramics as local drug delivery agents in such instances offers a safer, efficient mode of antibiotic delivery at the surgical site either to treat an incumbent infection or provide prophylactic benefit. Antibacterial bioceramics have also been developed by incorporating antibacterial ions, which have great potential to overcome antibiotic resistance. Both the approaches have been widely researched using in vitro and in vivo models. This chapter discusses the antibacterial potential of bioceramic nanoparticles with emphasis on combating bone infections.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84978334839&origin=inward; http://dx.doi.org/10.1007/978-3-319-12460-5_58; http://link.springer.com/10.1007/978-3-319-12460-5_58; http://link.springer.com/content/pdf/10.1007/978-3-319-12460-5_58; https://dx.doi.org/10.1007/978-3-319-12460-5_58; https://link.springer.com/referenceworkentry/10.1007/978-3-319-12460-5_58
Springer Nature America, Inc
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know